Description
Human Recombinant LDHA is available at Gentaur for Next week delivery.
Catalyzes the final step of anaerobic glycolysis
Biomolecule/Target:
Alternates names: L-lactate dehydrogenase A chain, GSD11, LDH1, LDHM, PIG19.
Synonyms: Human Recombinant LDHA
Background Information: LDHA catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. LDHA is localized primarily in muscle tissue and is part of the lactate dehydrogenase family. Mutations in LDHA have been linked to exertional myoglobinuria. LDH1 is decreased in essential thrombocythemia. LDHA is induced through a non-genomic pathway of estrogen action. Reduction in LDH-A activity results in stimulation of mitochondrial respiration and decrease of mitochondrial membrane potential.
Reconstitution Instructions: N/A
NCBI Gene Symbol: LDHA
Gene ID: 3939
NCBI Accession: P00338
Additional Information
Size: |
100 μg |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
Yes |
Source: |
E. Coli |
Purity by SDS-PAGE: |
≥95% |
Assay: |
SDS-PAGE |
Purity: |
N/A |
Assay 2: |
N/A |
Endotoxin Level: |
N/A |
Activity (Specifications/test method): |
N/A |
Biological activity: |
Specific activity is >20 units/mg. |
Results: |
>20 units/mg |
Molecular Weight: |
38.8 kDa (352 aa, 1-332 aa + His-Tag) |
Storage Temperature: |
-20°C |
Shelf Life: |
12 months |
Concentration: |
0.5 mg/ml |
Appearance: |
Liquid |
Handling: |
Centrifuge the vial prior to opening. |